Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Caesars Entertainment
CZR
$5.28B
| $41.6M | 0.03% |
851,500
-19,900
| -2% | -$971K |
|
502
Texas Pacific Land
TPL
$21B
| $41.5M | 0.03% |
73,251
-2,100
| -3% | -$1.19M |
|
503
Dell
DELL
$82B
| $41.2M | 0.03% |
1,025,708
-54,100
| -5% | -$2.18M |
|
504
Qorvo
QRVO
$8.53B
| $40.8M | 0.03% |
401,445
-18,000
| -4% | -$1.83M |
|
505
Fox Class A
FOXA
$27.8B
| $40.8M | 0.03% |
1,197,434
-48,500
| -4% | -$1.65M |
|
506
RB Global
RBA
$21.5B
| $40.8M | 0.03% |
725,443
+258,243
| +55% | +$14.5M |
|
507
Qiagen
QGEN
$10.2B
| $40.7M | 0.03% |
841,520
-32,091
| -4% | -$1.55M |
|
508
Charles River Laboratories
CRL
$7.97B
| $40.7M | 0.03% |
201,800
-4,900
| -2% | -$989K |
|
509
United Therapeutics
UTHR
$18.3B
| $40.5M | 0.03% |
180,955
+71,055
| +65% | +$15.9M |
|
510
CarMax
KMX
$9.21B
| $40.3M | 0.03% |
626,700
-20,500
| -3% | -$1.32M |
|
511
Globe Life
GL
$11.4B
| $40.2M | 0.03% |
365,800
-10,400
| -3% | -$1.14M |
|
512
Carnival Corp
CCL
$42.8B
| $40.2M | 0.03% |
3,964,000
-47,800
| -1% | -$485K |
|
513
Zscaler
ZS
$43.8B
| $40.1M | 0.03% |
343,300
-2,600
| -0.8% | -$304K |
|
514
Dayforce
DAY
$10.9B
| $40.1M | 0.03% |
547,300
-12,500
| -2% | -$915K |
|
515
Eastman Chemical
EMN
$7.91B
| $40.1M | 0.03% |
474,900
-24,200
| -5% | -$2.04M |
|
516
Gen Digital
GEN
$18.4B
| $39.9M | 0.03% |
2,326,375
-107,000
| -4% | -$1.84M |
|
517
HEICO Class A
HEI.A
$34.8B
| $39.7M | 0.03% |
292,395
-5,500
| -2% | -$747K |
|
518
NIO
NIO
$14.1B
| $39.7M | 0.03% |
3,776,217
+63,900
| +2% | +$672K |
|
519
American Homes 4 Rent
AMH
$12.9B
| $39.5M | 0.03% |
1,256,817
-15,200
| -1% | -$478K |
|
520
Crown Holdings
CCK
$10.9B
| $39.3M | 0.03% |
474,800
-17,700
| -4% | -$1.46M |
|
521
Liberty Broadband Class C
LBRDK
$8.68B
| $39.1M | 0.03% |
478,668
-30,400
| -6% | -$2.48M |
|
522
Teva Pharmaceuticals
TEVA
$22.6B
| $39M | 0.03% |
4,401,400
-108,600
| -2% | -$961K |
|
523
Molson Coors Class B
TAP
$9.86B
| $38.9M | 0.03% |
752,600
-20,900
| -3% | -$1.08M |
|
524
Neurocrine Biosciences
NBIX
$14.3B
| $38.5M | 0.03% |
380,500
-8,200
| -2% | -$830K |
|
525
Telus
TU
$25.1B
| $37.9M | 0.03% |
1,909,265
-67,100
| -3% | -$1.33M |
|